智通财经APP讯，华立股份(603038.SH)发布公告，此前披露，公司拟通过现金方式收购现有股东持有 的中科汇联51%的股份。本次交易各方未能就交易核心条款达成共识，公司于近期已收到标的公司股东 方面送达的终止本次收购意向的《函》。 ...

本次交易自启动以来，公司严格恪守约定，积极推进审计评估等各项前期尽调工作，及时履行信息披露 义务。但交易各方未能就交易核心条款达成共识，公司于近期已收到标的公司股东方面送达的终止本次 收购意向的《函》。为维护公司及全体股东的合法权益，经公司审慎研究，决定终止本次收购。 格隆汇12月29日丨华立股份(603038.SH)公布，公司于2025年10月30日与北京中科汇联科技股份有限公 司(以下简称"中科汇联"或"标的公司")的股东游世学、北京中科汇合控股有限公司、北京合和汇科技中 心(有限合伙)、罗敏、华纳沣佳企业管理(北京)合伙企业(有限合伙)、周瑞香、嘉兴君宁股权投资基金合 伙企业(有限合伙)、张成方、北京财富华纳投资有限公司、游利芳、李建成、于韶光、黄趁速、芜湖市 中太银信股权投资合伙企业(有限合伙)、张燕芝(以下合称"现有股东")签署了意向性协议，公司拟通过 现金方式收购现有股东持有的中科汇联51%的股份。 ...

华立股份公告称，公司于2025年10月30日拟现金收购中科汇联现有股东持有的51%股份并签署意向性协 议。自交易启动，公司积极推进前期尽调并履行信披义务，但交易各方未就核心条款达成共识，公司近 期收到标的公司股东终止收购意向的《函》。经审慎研究，公司决定终止本次收购。协议终止系双方协 商一致，无违约追责情形，对公司生产经营、财务状况无重大不利影响。 ...

证券日报网讯12月10日，华立股份（603038）在互动平台回答投资者提问时表示，公司产品有出口业 务，根据2024年年度报告数据，2024年公司境外业务收入占主营业务收入比例约为10%，其中有少量出 口欧盟国家，业务占比相对较少。 ...

1．案件所处的诉讼阶段：法院已开庭审理，原告撤诉 2．上市公司所处的当事人地位：公司、控股子公司福建尚润投资管理有限 公司作为被告方。 证券代码：603038 证券简称：华立股份 公告编号：2025-067 东莞市华立实业股份有限公司 关于公司及控股子公司诉讼事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 特别提示： 公司近日收到淄博市周村区人民法院出具的民事裁定书(2025)鲁 0306 民初 2973 号。具体情况如下： 原告：淄博金财公有资产经营有限公司 被告 1：福建尚润投资管理有限公司 3．涉案金额：(2025)鲁 0306 民初 2973 号诉讼涉案金额为 8,527.08 万元及 相关诉讼费用。 4．是否会对上市公司损益产生负面影响：截至本公告披露日，(2025)鲁 0306 民初 2973 号诉讼原告已撤诉，对公司本期利润或期后利润不构成影响。 一、基本情况 东莞市华立实业股份有限公司（以下简称"公司"）于 2025 年 8 月 16 日披 露公司及控股子公司福建尚润投资管理有限公司（以下 ...

华立股份晚间公告，公司及控股子公司尚润资本作为被告的诉讼案件中，原告淄博金财公有资产经营有 限公司已撤诉。该诉讼涉案金额为8527.08万元及相关诉讼费用。法院裁定准许原告撤诉，案件受理费 和财产保全费共计5025元由原告负担。此诉讼的撤诉不会对公司本期利润或期后利润产生影响。 ...

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Group 1 - Core viewpoint: Huali Co., Ltd. announced a contract for equipment procurement and installation with its joint venture company, Xinjiang Herun Yiyuan, amounting to approximately 59.2847 million yuan, which will enhance the company's market competitiveness and business expansion [1][1][1] - The project involves a water plant in Xinjiang and operates under a DBFOT model with a 30-year concession [1][1][1] - The transaction is conducted at fair market prices, ensuring no benefit transfer or infringement of the company's interests, maintaining the company's independence [1][1][1] Group 2 - For the fiscal year 2024, Huali Co., Ltd.'s revenue composition is as follows: 81.66% from decorative composite materials manufacturing, 15.17% from smart water services, and 3.17% from other businesses [1][1][1] - As of the report date, Huali Co., Ltd. has a market capitalization of 4.7 billion yuan [1][1][1]

Core Viewpoint - Huali Co., Ltd. (603038.SH) aims to expand its smart water management business in Xinjiang by introducing ultrafiltration water treatment equipment and a smart water management software platform [1] Group 1: Business Expansion - The company’s membrane filtration division, Jiangsu Nuo Lai Smart Water Equipment Co., Ltd., plans to adopt a "joint venture + membrane filtration equipment sales" model to penetrate the Xinjiang market [1] - Jiangsu Nuo Lai has signed a contract with its joint venture partner, Xinjiang He Run Yi Yuan Water Treatment Technology Co., Ltd., for the procurement and installation of equipment [1] Group 2: Financial Details - The total contract amount for the equipment, technical services, and warranty services is tentatively set at 59.2847 million yuan [1]

证券代码：603038 证券简称：华立股份 公告编号：2025-066 东莞市华立实业股份有限公司 关于下属公司与关联方签订采购合同暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 为进一步开拓新疆地区智慧水务业务，实现超滤水处理装备及智慧 水务软件平台打入新疆市场。公司膜滤事业部下属公司江苏诺莱智慧水务装 备有限公司（以下简称"江苏诺莱"）拟采取"参股+膜滤装备销售"模式， 与其联营公司新疆河润忆源水处理科技有限公司（以下简称"新疆河润忆 源"）签署设备采购安装合同，新疆河润忆源拟向江苏诺莱采购合同设备、 技术服务和质保期服务，合同总金额暂定为 5,928.47 万元。 本次交易不构成重大关联交易，亦不构成《上市公司重大资产重组 管理办法》规定的重大资产重组。 本次关联交易已事先经公司独立董事专门会议和董事会审计委员会 审议通过后提交董事会审议通过。因本次关联交易金额未达到公司最近一期 经审计净资产绝对值 5%，无需提交股东会审议。 至本次关联交易为止，过去 12 个月内公司与新疆河润忆 ...